Hanyang Med Rev.  2017 May;37(1):10-17. 10.7599/hmr.2017.37.1.10.

Review and update for central serous chorioretinopathy

Affiliations
  • 1Department of ophthalmology, Hanyang University Guri Hospital, Gyeonggi-do, Korea. syu2000@hanmail.net

Abstract

Central serous chorioretinopathy (CSC) is an eye disease that causes serous retinal detachment in the posterior pole of the retina. The pathogenesis of CSC is not fully understood and various systemic factors have been reported to be associated with CSC. Recently, with the advent of advanced imaging techniques, novel imaging findings for CSC have been reported and the understanding of CSC has increased further. Moreover, in addition to conventional treatment for CSC, new treatment modalities such as photodynamic therapy, anti-vascular endothelial growth factor or subthreshold laser therapy, have emerged. In this article, an overall review and update of CSC, particularly focusing on new imaging findings and treatments, will be discussed.

Keyword

Central serous chorioretinopathy; Imaging; Optical coherence tomography; Photodynamic therapy

MeSH Terms

Central Serous Chorioretinopathy*
Endothelial Growth Factors
Eye Diseases
Laser Therapy
Photochemotherapy
Retina
Retinal Detachment
Tomography, Optical Coherence
Endothelial Growth Factors
Full Text Links
  • HMR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr